Skip to main content

#157971

MCF7 ZsGreen-ZNF703 Lenti-control Cell Line

Cat. #157971

MCF7 ZsGreen-ZNF703 Lenti-control Cell Line

Cat. #: 157971

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 8-10 weeks

Organism: Human

Tissue: Breast

Disease: Cancer

Model: Tumour line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Carlos Caldas

Institute: University of Cambridge

Tool Details
Target Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: MCF7 ZsGreen-ZNF703 Lenti-control Cell Line
  • Research fields: Cancer
  • Tool sub type: Continuous
  • Parental cell: MCF7
  • Organism: Human
  • Tissue: Breast
  • Disease: Cancer
  • Model: Tumour line
  • Conditional: No
  • Description: The MCF7 breast cancer human cell line infected with a control lentivirus (lenti-control) with no gene of interest. ZNF703 drives the exprsesion of the green fluorescent protein ZsGreen. This cell line serves as the negative control for the the MCF7-ZsGreen-ZNF703 overexpressing cell line (see Related tab).
  • Biosafety level: 1

Target Details

  • Target: Negative control for Zinc Finger Protein 703 (ZNF703) (UniProt ID: Q9H7S9)

Applications

  • Application notes: The pHIV-Zsgreen plasmid was cloned by removing the U6-TATAlox-CMVie-EGFP-TATAlox-WPRE content of the pSICO plasmid (Ventura et al., 2004). ZsGreen is used as a reporter for ZNF703.

Handling

  • Format: Frozen
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Storage conditions: Liquid Nitrogen
  • Mycoplasma free: Yes

Related Tools

  • Related tools: MCF7 ZsGreen-ZNF703 Overexpressing Cell Line

References

  • Holland et al. 2011. EMBO Mol Med. 3(3):167-80. PMID: 21337521.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.